CBD + CBG 500 mg

Other Combinations

Brand: Steve's Goods

LiquidOn Market
Click to view full label

Net Contents

1 fl. Oz.; 30 mL

Serving Size

83.33 mg [1 mL]

Servings Per Container

Not specified

Supplement Form

Liquid

Bar Code (UPC/SKU)

8 50008 95545 7

Product Version

Not specified

Suggested Use

Directions: Shake well before each use. Take as needed (refer to dosage table). Place drops under the tongue for 30 seconds before swallowing.

Where to Buy Locally

Enter your city or ZIP code to find supplement & health stores in your area that may carry this product.

Showing representative supplement & health retailers — search above for stores in your area.

Research & Studies

  • … -controlled, repeated-dose pilot study of the safety, tolerability, and preliminary effects of a cannabidiol (CBD)-and cannabigerol (CBG)-based beverage powder to …

    EN Peters, H Yardley, A Harrison… - Journal of the …, 2023 - Taylor & Francis

    … Older work supports that CBG has gamma … ) or CBD, suggesting muscle relaxant properties [Citation14]. In one survey, a product containing 15 mg/mL CBG plus 5 mg/mL of CBD was …

    202342 citations
  • Cannabidiol in foods and food supplements: evaluation of health risks and health claims

    BE Engeli, DW Lachenmeier, P Diel, S Guth… - Nutrients, 2025 - mdpi.com

    … if CBD at doses below the LOAEL of 4.3–5 mg/kg bw per day (<300 mg/day) causes scientifically reproducible positive health … oral intake of CBD-containing foods/food supplements, to …

    202520 citations
  • Possible role of cannabis in the management of neuroinflammation in patients with post-COVID condition

    N Cárdenas-Rodríguez, I Ignacio-Mejía… - International Journal of …, 2024 - mdpi.com

    … PCC presents significant challenges to neurological health, and neuroinflammation and oxidative stress play central roles in its pathogenesis. Antioxidant therapy and cannabinoid-…

    20249 citations
  • The Impact of CBD and CBG on Gut and Mental Health

    L Poehlein - 2025 - search.proquest.com

    … of how CBD and CBG affect health through … cannabinoid and endocannabinoid compounds, and how they impact anxiety in mice. This report provides new evidence that CBD and CBG …

    2025
  • Cannabinoids for medical use: a systematic review and meta-analysis

    PF Whiting, RF Wolff, S Deshpande, M Di Nisio, S Duffy… - Jama, 2015 - jamanetwork.com

    … with cannabinoid compared with placebo, stratified according to … CBD Use does not appear to be explicitly restricted Active cannabinoid part of cannabis Capsules (oral) 200-800 mg/d …

    20153,191 citations
  • Plasma and brain pharmacokinetic profile of cannabidiol (CBD), cannabidivarine (CBDV), Δ9-tetrahydrocannabivarin (THCV) and cannabigerol (CBG) in rats and …

    S Deiana, A Watanabe, Y Yamasaki, N Amada… - …, 2012 - Springer

    … concentrations for CBD (120 mg/kg) and CBDV (60 mg/kg), but not for Δ 9 -THCV (30 mg/kg) and CBG (120 mg/kg), for which the intraperitoneal route was more effective. CBD inhibited …

    2012510 citations

Data sourced from the U.S. National Institutes of Health, Office of Dietary Supplements Dietary Supplement Label Database (DSLD) · Label entered 2021-04-22. DSLD Label ID: 247012. This information is provided for educational reference only and is not medical advice. Always follow the product label and consult a doctor or pharmacist before use.